These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 27618739)

  • 1. Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward.
    Volkow ND; Hampson AJ; Baler RD
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():285-308. PubMed ID: 27618739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contributions of the endocannabinoid system and stress on the neural processing of reward stimuli.
    Filbey FM; Beaton D; Prashad S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110183. PubMed ID: 33221340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and Endocannabinoid Signaling in Epilepsy.
    Katona I
    Handb Exp Pharmacol; 2015; 231():285-316. PubMed ID: 26408165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid system, stress and HPA axis.
    Micale V; Drago F
    Eur J Pharmacol; 2018 Sep; 834():230-239. PubMed ID: 30036537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoid lipids and mediated system: implications for alcoholism and neuropsychiatric disorders.
    Vinod KY; Hungund BL
    Life Sci; 2005 Aug; 77(14):1569-83. PubMed ID: 16005471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders.
    Morris G; Walder K; Berk M; Carvalho AF; Marx W; Bortolasci CC; Yung AR; Puri BK; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2022 Mar; 114():110481. PubMed ID: 34826557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.
    Jacobson MR; Watts JJ; Boileau I; Tong J; Mizrahi R
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):330-348. PubMed ID: 30635160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.
    Wyrofsky R; McGonigle P; Van Bockstaele EJ
    Expert Opin Drug Discov; 2015 Jan; 10(1):17-36. PubMed ID: 25488672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis in liver disorders: a friend or a foe?
    Goyal H; Rahman MR; Perisetti A; Shah N; Chhabra R
    Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1283-1290. PubMed ID: 30169449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid system in irritable bowel syndrome and cannabis as a therapy.
    Pandey S; Kashif S; Youssef M; Sarwal S; Zraik H; Singh R; Rutkofsky IH
    Complement Ther Med; 2020 Jan; 48():102242. PubMed ID: 31987224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis: A Treasure Trove or Pandora's Box?
    Solymosi K; Köfalvi A
    Mini Rev Med Chem; 2017; 17(13):1223-1291. PubMed ID: 27719666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring.
    Alpár A; Di Marzo V; Harkany T
    Biol Psychiatry; 2016 Apr; 79(7):e33-45. PubMed ID: 26549491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis and the Gastrointestinal Tract.
    Cohen L; Neuman MG
    J Pharm Pharm Sci; 2020; 23():301-313. PubMed ID: 32762830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endocannabinoid system in mental diseases.
    Manzanares J; Urigüen L; Rubio G; Palomo T
    Neurotox Res; 2004; 6(3):213-24. PubMed ID: 15325960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids and Mental Disorders.
    Rubino T; Zamberletti E; Parolaro D
    Handb Exp Pharmacol; 2015; 231():261-83. PubMed ID: 26408164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies.
    Sloan ME; Grant CW; Gowin JL; Ramchandani VA; Le Foll B
    Acta Pharmacol Sin; 2019 Mar; 40(3):342-350. PubMed ID: 30166624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A role for the endocannabinoid system in obesity].
    Valenzuela C; Aguirre C; Castillo V; Ronco AM; Llanos M
    Rev Med Chil; 2010 May; 138(5):621-9. PubMed ID: 20668819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endocannabinoidome in neuropsychiatry: Opportunities and potential risks.
    Morris G; Walder K; Kloiber S; Amminger P; Berk M; Bortolasci CC; Maes M; Puri BK; Carvalho AF
    Pharmacol Res; 2021 Aug; 170():105729. PubMed ID: 34119623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid disruption of learning mechanisms involved in reward processing.
    Lupica CR; Hoffman AF
    Learn Mem; 2018 Sep; 25(9):435-445. PubMed ID: 30115765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology.
    Ligresti A; De Petrocellis L; Di Marzo V
    Physiol Rev; 2016 Oct; 96(4):1593-659. PubMed ID: 27630175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.